Search

Your search keyword '"Irwin, Margaret"' showing total 169 results

Search Constraints

Start Over You searched for: Author "Irwin, Margaret" Remove constraint Author: "Irwin, Margaret"
169 results on '"Irwin, Margaret"'

Search Results

3. Safety, immunogenicity, and reactogenicity of BNT162b2 and mRNA-1273 COVID-19 vaccines given as fourth-dose boosters following two doses of ChAdOx1 nCoV-19 or BNT162b2 and a third dose of BNT162b2 (COV-BOOST): a multicentre, blinded, phase 2, randomised trial

5. Safety and immunogenicity of seven COVID-19 vaccines as a third dose (booster) following two doses of ChAdOx1 nCov-19 or BNT162b2 in the UK (COV-BOOST): a blinded, multicentre, randomised, controlled, phase 2 trial

7. Lowering the Age of Consent for Vaccination to Promote Pediatric Vaccination: It's Worth a Shot.

10. Patterns, perceptions, and perceived barriers to physical activity in adult cancer survivors

14. COVID-19–Associated Croup in Children

17. Safety and immunogenicity of seven COVID-19 vaccines as a third dose (booster) following two doses of ChAdOx1 nCov-19 or BNT162b2 in the UK (COV-BOOST): a blinded, multicentre, randomised, controlled, phase 2 trial

26. Emergency preparedness curriculum in nursing schools in the United States

32. Impact of immigration status on health behaviors and perceptions in cancer survivors

34. CAI at CSDF: Organizational Strategies.

37. EQ-5D Health Utility Scores: Data from a Comprehensive Canadian Cancer Centre

38. Patterns, perceptions, and perceived barriers to physical activity in adult cancer survivors.

39. Feasibility and diagnostic accuracy of the Patient-Reported Outcomes Measurement Information System (PROMIS) item banks for routine surveillance of sleep and fatigue problems in ambulatory cancer care

40. Abstract B15: Second-hand smoke (SHS) and smoking cessation in non-tobacco related cancers

44. Stage specific health utility index scores of Canadian cancer patients.

45. Improving quality of care by obtaining patient-reported outcomes (PRO)-CTCAE chemotoxicities using tablet technology in daycare (DC) waiting rooms.

46. Canadian cancer site-specific health utility values: Creating the basis for measuring value and costs of therapy.

47. Involving clinic patients in systematic symptom reporting to improve cancer care: Exploring prevalence of sleep disturbances (SD) and fatigue (FAT).

48. Involving patients to improve their care through real-time patient reported outcome (PRO)-CTCAE chemotoxicity surveys in an outpatient chemodaycare (DC) setting: Evaluating patient acceptability.

49. Effect of physical activity (PA) perceptions in cancer survivors on PA behaviors: Helping health care providers improve patient communication.

50. Using tablet technology in routine patient-reported outcome measure surveys to improve cancer quality care: A patient acceptability assessment.

Catalog

Books, media, physical & digital resources